ResearcherKyoto Prefectural University of MedicineNo recent work listed

Juichiro Yoshida

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2685-5993; OpenAlex author ID A5113427115. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper

Papers 1

Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. Co-author DOI 10.3892/or.2020.7595 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takeshi Ishikawa · 1 shared paper, 2020 · strength 0.09
- Paper Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. DOI 10.3892/or.2020.7595 ↗
Tomohisa Takagi · 1 shared paper, 2020 · strength 0.09
- Paper Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. DOI 10.3892/or.2020.7595 ↗
Yoshito Itoh · 1 shared paper, 2020 · strength 0.09
- Paper Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells. DOI 10.3892/or.2020.7595 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.